Tag
- Gilead Sciences Reports Q3 2023 Financial Results 2023-11-09
- The battle between Pfizer and Gilead over COVID-19 drugs wil... 2022-11-03
- FDA Lifts Clinical Hold on Gilead's HIV Drug Lenacapavir 2022-05-18
- Gilead's CD47 Monoclonal Antibody Clinical Trial Was 'Unbloc... 2022-04-20
- Gilead: Remdesivir sold $1.93 billion in Q4 2021-02-08
- Sinopharm and Gilead announce cooperation 2020-09-14
- Pfizer signs deal to manufacture Gilead's remdesivir 2020-08-10
- Gilead announces results from Phase 3 Trial of remdesivir in... 2020-06-15
- Gilead may struggle to expand remdesivir's market to moderat... 2020-05-18
- Gilead's Japanese remdesivir nod, licensing talks; Lilly-Jun... 2020-05-09
Market Analysis
- Market Analysis - Monthly Report - August 2022- Hot Products Nov-22,2022
- Market Analysis - Monthly Report - July 2022- Hot Products Aug-02,2022
- Market Analysis - Weekly Report - July 4th to July 8th, 2022- Hot Products Jul-18,2022
- Market Analysis - Monthly Report - June, 2022- Hot Products Jul-11,2022
- Market Analysis - Weekly Report - June 13th to June 17th, 2022- Hot Products Jun-21,2022